scispace - formally typeset
T

Thomas G. Gross

Researcher at National Institutes of Health

Publications -  293
Citations -  12243

Thomas G. Gross is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 55, co-authored 281 publications receiving 10635 citations. Previous affiliations of Thomas G. Gross include University of California, Los Angeles & University of Cincinnati.

Papers
More filters
Journal ArticleDOI

Real-World Evidence — What Is It and What Can It Tell Us?

TL;DR: The FDA is developing guidance on the use of “real-world evidence” — health care information from atypical sources, including electronic health records, billing databases, and product and disease registries — to assess the safety and effectiveness of drugs and devices.
Journal ArticleDOI

Malignancy after transplantation.

TL;DR: Although calcineurin inhibitors and azathioprine have been linked with posttransplant malignancies, newer agents such as mycophenolate mofetil and sirolimus have not and indeed may have antitumor properties and long-term data are needed to determine if the use of these agents will ultimately lower the mortality due to malignancy for transplant recipients.
Journal ArticleDOI

X-linked lymphoproliferative disease: twenty-five years after the discovery.

TL;DR: The X-linked lymphoproliferative disease (XLP), one of six described X- linked immunodeficiencies, stems from a mutation at Xq25 which renders males impotent to mount an effective immune response to the ubiquitous EBV.
Journal ArticleDOI

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

TL;DR: The issue of lymphoma and IBD therapy is reviewed and clinical options in light of this new information are explored.